SARS-CoV-2 vaccination diversifies the CD4+ spike-reactive T cell repertoire in patients with prior SARS-CoV-2 infection

Dykema, AG; Zhang, BY; Woldemeskel, BA; Garliss, CC; Rashid, R; Westlake, T; Zhang, L; Zhang, JJ; Cheung, LS; Caushi, JX; Pardoll, DM; Cox, AL; Ji, HK; Smith, KN; Blankson, JN

Smith, KN (通讯作者),Johns Hopkins Univ, Bloomberg Kimmel Inst Canc Immunotherapy, Baltimore, MD 21218 USA.;Blankson, JN (通讯作者),Johns Hopkins Univ, Sch Med, Dept Med, Baltimore, MD 21205 USA.

EBIOMEDICINE, 2022; 80 ():

Abstract

Background COVID-19 mRNA vaccines elicit strong T and B cell responses to the SARS-CoV-2 spike glycoprotein in both SARS-CoV-2 nayve and experienced p......

Full Text Link